Monogram Orthopaedics (MGRM) Competitors $2.00 -0.04 (-1.96%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends MGRM vs. NPCE, ZYXI, ELMD, LUNG, SKIN, PROF, SGHT, ZJYL, SONX, and BWAYShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include NeuroPace (NPCE), Zynex (ZYXI), Electromed (ELMD), Pulmonx (LUNG), Beauty Health (SKIN), Profound Medical (PROF), Sight Sciences (SGHT), Jin Medical International (ZJYL), Sonendo (SONX), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. NeuroPace Zynex Electromed Pulmonx Beauty Health Profound Medical Sight Sciences Jin Medical International Sonendo BrainsWay Monogram Orthopaedics (NASDAQ:MGRM) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Does the MarketBeat Community favor MGRM or NPCE? NeuroPace received 27 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. CompanyUnderperformOutperformMonogram OrthopaedicsN/AN/ANeuroPaceOutperform Votes2757.45% Underperform Votes2042.55% Is MGRM or NPCE more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to NeuroPace's net margin of -36.74%. Monogram Orthopaedics' return on equity of -130.90% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets Monogram OrthopaedicsN/A -130.90% -106.38% NeuroPace -36.74%-205.41%-28.29% Does the media prefer MGRM or NPCE? In the previous week, NeuroPace had 8 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 11 mentions for NeuroPace and 3 mentions for Monogram Orthopaedics. NeuroPace's average media sentiment score of 0.85 beat Monogram Orthopaedics' score of 0.35 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Monogram Orthopaedics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroPace 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, MGRM or NPCE? Monogram Orthopaedics has a beta of 2.28, suggesting that its stock price is 128% more volatile than the S&P 500. Comparatively, NeuroPace has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Which has stronger earnings & valuation, MGRM or NPCE? Monogram Orthopaedics has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMonogram Orthopaedics$370K185.46-$13.74M-$0.47-4.26NeuroPace$65.42M4.19-$32.96M-$1.00-9.19 Do insiders and institutionals believe in MGRM or NPCE? 0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by company insiders. Comparatively, 22.2% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer MGRM or NPCE? NeuroPace has a consensus target price of $14.60, indicating a potential upside of 58.87%. Given NeuroPace's stronger consensus rating and higher possible upside, analysts clearly believe NeuroPace is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummaryNeuroPace beats Monogram Orthopaedics on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$70M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-4.2613.2787.8613.46Price / Sales185.4644.831,228.8287.66Price / CashN/A52.2739.5136.27Price / Book3.925.776.946.30Net Income-$13.74M$13.76M$119.12M$225.93M7 Day Performance-0.50%-1.10%-1.84%-1.32%1 Month Performance-19.35%0.56%-3.65%0.60%1 Year Performance-36.31%50.90%31.64%26.23% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics1.1098 of 5 stars$2.00-2.0%N/A-38.8%$70M$370,000.00-4.2628NPCENeuroPace3.7719 of 5 stars$9.19+0.1%$14.60+58.9%+5.6%$274.01M$65.42M0.00170Analyst RevisionZYXIZynex3.7354 of 5 stars$7.86+0.5%$14.00+78.1%-12.6%$249.03M$184.32M52.401,100ELMDElectromedN/A$29.21+4.6%N/A+181.9%$247.06M$57.06M40.57174LUNGPulmonx2.5845 of 5 stars$6.20+3.3%$14.67+136.6%-42.9%$236.93M$68.68M0.00250SKINBeauty Health2.6897 of 5 stars$1.49-7.5%$2.55+71.1%-36.3%$200.29M$398M0.001,030Analyst RevisionPositive NewsPROFProfound Medical2.4531 of 5 stars$7.69-1.8%$13.75+78.8%-31.2%$193.10M$7.20M0.00150Positive NewsSGHTSight Sciences2.5151 of 5 stars$3.73-1.1%$5.50+47.5%+63.6%$191.35M$81.06M0.00210ZJYLJin Medical InternationalN/A$1.01-16.5%N/A-94.1%$187.55M$19.82M0.00245Positive NewsGap DownHigh Trading VolumeSONXSonendoN/A$2.16+1.4%N/A+815.3%$180.60M$44.40M-4.80250Positive NewsGap UpBWAYBrainsWay3.9884 of 5 stars$9.83+1.7%$13.17+33.9%+103.9%$161.28M$31.78M98.31120Gap Up Related Companies and Tools Related Companies NeuroPace Competitors Zynex Competitors Electromed Competitors Pulmonx Competitors Beauty Health Competitors Profound Medical Competitors Sight Sciences Competitors Jin Medical International Competitors Sonendo Competitors BrainsWay Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MGRM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGRM Stock Alerts